COVID-19 Pandemic: An Unseen’s Evolution War

DOI: https://doi.org/10.22502/jlmc.v8i1.354
Keywords: Covid-19, Malaysia, Social distancing

Abstract

This is a new beginning. It started just like a fiction movie.
In December 2019, a new cluster of pneumonia caused by the 2019 novel coronavirus (2019-nCoV) was first identified in Wuhan, China. Without any mercy, it became a pandemic and left no time for grief. It was not only life-threatening but also challenged our healthcare system, economy, culture, lifestyle and belief. It forced us to make changes. We need to evolve, and we must evolve. Malaysia, a multi-ethnicity and multireligious
country which is located in Southeast Asia, has a population of 32 million with a median age of 28.9 years in 2019. According to the Observatory of Economic Complexity, Malaysia has experienced rapid globalization and is the 19th leading exporter in the world. It is an upper-middle-income country with a gross domestic product (GDP) of 370 billion USD in 2019, of which 4.5% is funded to the healthcare system.

Downloads

Download data is not yet available.

Author Biographies

Quek Yek Song, Columbia Asia Hospital, Iskandar Puteri, Malaysia.

Seinor Adjunct Lecturer,

Monash University, Malaysia, Columbia Asia Hospital, Iskandar Puteri, Malaysia.

Michelle Jia Ni Ling, Monash University, Malaysia.

Medical student,

Monash University, Malaysia.

References

Fei Zhou, Ting Yu, Ronghui Du, Guohui Fan, Ying Liu, Zhibo Liu, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395: 1054–62. DOI: https://doi.org/10.1016/S0140-6736(20)30566-3

Mahidin MU. Current Population Estimates, Malaysia, 2018-2019. Department of Statistics, Malaysia, Official Portal. 2019 July 15. Available from: https://www.dosm.gov.my/v1/index.php?r=column/cthemeByCat&cat=155&bul_id=aWJZRkJ4UEdKcUZpT2tVT090Snpy-dz09&menu_id=L0pheU43NWJwRWVSZkl¬WdzQ4TlhUUT09

Simoes A. Visualizations, Malaysia. The Obser¬vatory of Economic Complexity. 2017. Available from: https://oec.world/en/profile/country/mys/

Malaysia GDP 1960-2019 Data. Trading Eco¬nomics. 2020. Available from: https://trading-economics.com/malaysia/gdp

Code Blue. Health Care Financing: National Health Insurance or Tax-Based System? Code Blue. 2019 Mar 11. Available from: https://code¬blue.galencentre.org/2019/03/11/health-care-financing-national-health-insurance-or-tax-based-system/

Plecher H. Infant mortality rate in Malaysia 2018. Statista. 2020 Jan 29. Available from: https://www.statista.com/statistics/807002/infant-mortality-in-malaysia/.

Hirshmann R. Malaysia maternal mortality ratio 2011-2018. Statista. 2019 Nov 4. https://www.statista.com/statistics/642032/malaysia-maternal-mortality-ratio/

Malaysia Life Expectancy 1950-2020. Macro¬trends. 2020. Available from: https://www.mac-rotrends.net/countries/MYS/malaysia/life-expectancy

Lim S. From English-speaking doctors to afford¬able healthcare: Malaysia ranks 1st in healthcare category of global retirement index. Business Insider Malaysia, 2019 Feb 7. Available from: https://www.businessinsider.my/from-english-speaking-doctors-to-affordable-healthcare-malaysia-ranks-1st-in-the-healthcare-category-of-a-2019-global-retirement-index

Tandon A, Murray CJL, Lauer JA, Evans DB. Measuring overall health system performance for 191 countries. World Health Organization, GPE Discussion Paper Series: No. 30, page 18. Accessed from: https://www.who.int/healthinfo/paper30.pdf?ua=1

Covid-19 chronology in Malaysia. Bernama, 2020 Mar 17. Available from: https://www.bernama.com/en/general/news_covid-19.php?id=1821902

JP Morgan: Malaysia’s Covid-19 strategy far exceeds Asian, some European peers. New Straits Times. 2020 March 25. Available from: https://www.nst.com.my/business/2020/03/577996/jp-morgan-malaysias-covid-19-strategy-far-exceeds-asean-some-european-peers

Bernama. Malaysia ranked 4th in public opinion survey on govt response to Covid-19. The Edge Markets. 2020 May 8. Available from: https://www.theedgemarkets.com/article/malaysia-ranked-4th-public-opinion-survey-ovt-response-covid19

Pfordten D. Malaysia’s response to Covid-19 ranked fourth strictest in SEA. The Star. 2020 Apr 12. Available from: https://www.thestar.com.my/news/nation/2020/04/12/malaysia039s-response-to-covid-19-ranked-fourth-strictest-in-sea

Khairulrijal R. Covid-19: Maeps transformed into massive makeshift hospital. New Strait Times. 2020 Apr 4. Available from: https://www.nst.com.my/news/nation/2020/04/581248/covid-19-maeps-transformed-massive-makeshift-hospital

Published
2020-05-30
How to Cite
1.
Song Q, Ling M. COVID-19 Pandemic: An Unseen’s Evolution War. J Lumbini Med Coll [Internet]. 30May2020 [cited 4Oct.2024];8(1):138-41. Available from: https://jlmc.edu.np/index.php/JLMC/article/view/354
Issue
Vol 8 No 1 (2020): vol:8, No:1
Section
Perspective

Copyright (c) 2020 Quek Yek Song

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

  • The Journal of Lumbini Medical College (JLMC) publishes open access articles under the terms of the Creative Commons Attribution (CC BY) License which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  • JLMC requires an exclusive licence to publish the article first in its journal in print and online.
  • The corresponding author should read and agree to the following statement before submission of the manuscript for publication,
    • License agreement
    • In submitting an article to Journal of Lumbini Medical College (JLMC) I certify that:
      1. I am authorized by my co-authors to enter into these arrangements.
      2. I warrant, on behalf of myself and my co-authors, that:
        1. the article is original, has not been formally published in any other peer-reviewed journal, is not under consideration by any other journal and does not infringe any existing copyright or any other third party rights;
        2. I am/we are the sole author(s) of the article and have full authority to enter into this agreement and in granting rights to JLMC are not in breach of any other obligation;
        3. the article contains nothing that is unlawful, libellous, or which would, if published, constitute a breach of contract or of confidence or of commitment given to secrecy;
        4. I/we have taken due care to ensure the integrity of the article. To my/our - and currently accepted scientific - knowledge all statements contained in it purporting to be facts are true and any formula or instruction contained in the article will not, if followed accurately, cause any injury, illness or damage to the user.
      3. I, and all co-authors, agree that the article, if editorially accepted for publication, shall be licensed under the Creative Commons Attribution License 4.0. If the law requires that the article be published in the public domain, I/we will notify JLMC at the time of submission, and in such cases the article shall be released under the Creative Commons 1.0 Public Domain Dedication waiver. For the avoidance of doubt it is stated that sections 1 and 2 of this license agreement shall apply and prevail regardless of whether the article is published under Creative Commons Attribution License 4.0 or the Creative Commons 1.0 Public Domain Dedication waiver.
      4. I, and all co-authors, agree that, if the article is editorially accepted for publication in JLMC, data included in the article shall be made available under the Creative Commons 1.0 Public Domain Dedication waiver, unless otherwise stated. For the avoidance of doubt it is stated that sections 1, 2, and 3 of this license agreement shall apply and prevail.

                            Please visit Creative Commons web page for details of the terms.